+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe



Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe



Journal of Acquired Immune Deficiency Syndromes 48(4): 468-475



Good adherence is essential for successful antiretroviral therapy (ART) provision, but simple measures have rarely been validated in Africa. This was an observational analysis of an open multicenter randomized HIV/AIDS management trial in Uganda and Zimbabwe. At 4-weekly clinic visits, ART drugs were provided and adherence measured through pill usage and questionnaire. Viral load response was assessed in a subset of patients. Drug possession ratio (percentage of drugs taken between visits) defined complete (100%) and good (>or=95%) adherence. In 2,957 patients, 90% had pill counts at every visit. Good adherence increased from 87%, 4 weeks after ART initiation, to 94% at 48 weeks, but only 1,454 (49%) patients achieved good adherence at every visit in the first year. Complete adherence was associated with 0.32 greater reduction in log10 viral load (95% confidence interval 0.05, 0.60 P = 0.02) and was independently associated with higher baseline CD4 count, starting ART later in the trial, reporting a single regular sexual partner, clinical center, and time on ART. Population level adherence improved over time suggesting an association with clinical experience. Most patients had at least one visit in the year on which they reported not having good adherence, showing the need for continued adherence interventions.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 023338816

Download citation: RISBibTeXText

PMID: 18614918

DOI: 10.1097/qai.0b013e31817dc3fd


Related references

The impact of first year adherence to antiretroviral therapy on long-term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe. Tropical Medicine and International Health 17(5): 584-594, 2012

Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda. Journal of Acquired Immune Deficiency Syndromes 70(4): 386-392, 2015

The experience of "medicine companions" to support adherence to antiretroviral therapy: quantitative and qualitative data from a trial population in Uganda. Aids Care 22(Suppl. 1): 35-43, 2010

Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial. Plos one 8(10): E76158, 2013

Concomitant herbal medicine and Antiretroviral Therapy (ART) use among HIV patients in Western Uganda: a cross-sectional analysis of magnitude and patterns of use, associated factors and impact on ART adherence. Aids Care 24(11): 1375-1383, 2012

The Meanings in the messages: how SMS reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. Aids 30(8): 1287-1294, 2016

'I was thinking too much': experiences of HIV-positive adults with common mental disorders and poor adherence to antiretroviral therapy in Zimbabwe. Tropical Medicine and International Health 20(7): 903-913, 2015

Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. Aids 30(8): 1295-1300, 2016

Factors associated with self-reported adherence among adolescents on antiretroviral therapy in Zimbabwe. Aids Care 27(3): 322-326, 2015

Adherence to antiretroviral therapy in Jinja, Uganda: a six-year follow-up study. Plos one 8(10): E78243, 2013

Adherence to antiretroviral therapy among a conflict-affected population in Northeastern Uganda: a qualitative study. Aids 22(14): 1882-1884, 2008

Change in adherence level and outcome of HIV infection The importance of the consistency of adherence to antiretroviral therapy. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 42: 272, 2002

Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe. Journal of Acquired Immune Deficiency Syndromes 75(Suppl. 2): S198-S206, 2017

Improving clinic attendance and adherence to antiretroviral therapy through a treatment supporter intervention in Uganda: a randomized controlled trial. Aids and Behavior 15(8): 1795-1802, 2011

What causes non-adherence among some individuals on long term antiretroviral therapy? Experiences of individuals with poor viral suppression in Uganda. Aids Research and Therapy 16(1): 2, 2019